GILEAD SCIENCES INC (GILD) Fundamental Analysis & Valuation
NASDAQ:GILD • US3755581036
Current stock price
141.41 USD
+0.12 (+0.08%)
Last:
This GILD fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. GILD Profitability Analysis
1.1 Basic Checks
- In the past year GILD was profitable.
- In the past year GILD had a positive cash flow from operations.
- GILD had positive earnings in each of the past 5 years.
- Each year in the past 5 years GILD had a positive operating cash flow.
1.2 Ratios
- GILD has a Return On Assets of 14.42%. This is amongst the best in the industry. GILD outperforms 94.98% of its industry peers.
- Looking at the Return On Equity, with a value of 37.49%, GILD belongs to the top of the industry, outperforming 97.88% of the companies in the same industry.
- The Return On Invested Capital of GILD (19.49%) is better than 97.30% of its industry peers.
- The Average Return On Invested Capital over the past 3 years for GILD is in line with the industry average of 19.54%.
- The 3 year average ROIC (17.55%) for GILD is below the current ROIC(19.49%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 14.42% | ||
| ROE | 37.49% | ||
| ROIC | 19.49% |
ROA(3y)8.12%
ROA(5y)8.16%
ROE(3y)21.59%
ROE(5y)23.19%
ROIC(3y)17.55%
ROIC(5y)16.76%
1.3 Margins
- The Profit Margin of GILD (28.90%) is better than 95.17% of its industry peers.
- GILD's Profit Margin has improved in the last couple of years.
- The Operating Margin of GILD (39.98%) is better than 98.46% of its industry peers.
- GILD's Operating Margin has been stable in the last couple of years.
- GILD has a better Gross Margin (78.83%) than 84.56% of its industry peers.
- In the last couple of years the Gross Margin of GILD has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 39.98% | ||
| PM (TTM) | 28.9% | ||
| GM | 78.83% |
OM growth 3Y-1.4%
OM growth 5Y-0.11%
PM growth 3Y19.75%
PM growth 5Y125.27%
GM growth 3Y-0.18%
GM growth 5Y-0.66%
2. GILD Health Analysis
2.1 Basic Checks
- GILD has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
- The number of shares outstanding for GILD has been reduced compared to 1 year ago.
- GILD has less shares outstanding than it did 5 years ago.
- GILD has a better debt/assets ratio than last year.
2.2 Solvency
- An Altman-Z score of 4.51 indicates that GILD is not in any danger for bankruptcy at the moment.
- GILD has a Altman-Z score of 4.51. This is in the better half of the industry: GILD outperforms 72.59% of its industry peers.
- GILD has a debt to FCF ratio of 2.64. This is a good value and a sign of high solvency as GILD would need 2.64 years to pay back of all of its debts.
- Looking at the Debt to FCF ratio, with a value of 2.64, GILD belongs to the top of the industry, outperforming 93.05% of the companies in the same industry.
- A Debt/Equity ratio of 0.97 indicates that GILD is somewhat dependend on debt financing.
- GILD has a Debt to Equity ratio of 0.97. This is in the lower half of the industry: GILD underperforms 75.29% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.97 | ||
| Debt/FCF | 2.64 | ||
| Altman-Z | 4.51 |
ROIC/WACC2.37
WACC8.21%
2.3 Liquidity
- A Current Ratio of 1.55 indicates that GILD should not have too much problems paying its short term obligations.
- GILD's Current ratio of 1.55 is on the low side compared to the rest of the industry. GILD is outperformed by 80.89% of its industry peers.
- GILD has a Quick Ratio of 1.40. This is a normal value and indicates that GILD is financially healthy and should not expect problems in meeting its short term obligations.
- The Quick ratio of GILD (1.40) is worse than 81.66% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.55 | ||
| Quick Ratio | 1.4 |
3. GILD Growth Analysis
3.1 Past
- GILD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 76.79%, which is quite impressive.
- GILD shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 2.83% yearly.
- The Revenue has been growing slightly by 2.40% in the past year.
- GILD shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.58% yearly.
EPS 1Y (TTM)76.79%
EPS 3Y3.88%
EPS 5Y2.83%
EPS Q2Q%-2.11%
Revenue 1Y (TTM)2.4%
Revenue growth 3Y2.57%
Revenue growth 5Y3.58%
Sales Q2Q%4.7%
3.2 Future
- The Earnings Per Share is expected to grow by 10.10% on average over the next years. This is quite good.
- Based on estimates for the next years, GILD will show a small growth in Revenue. The Revenue will grow by 5.49% on average per year.
EPS Next Y8.46%
EPS Next 2Y9.79%
EPS Next 3Y9.45%
EPS Next 5Y10.1%
Revenue Next Year3.46%
Revenue Next 2Y4.77%
Revenue Next 3Y4.94%
Revenue Next 5Y5.49%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. GILD Valuation Analysis
4.1 Price/Earnings Ratio
- Based on the Price/Earnings ratio of 17.35, the valuation of GILD can be described as rather expensive.
- 94.02% of the companies in the same industry are more expensive than GILD, based on the Price/Earnings ratio.
- GILD's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 25.79.
- The Price/Forward Earnings ratio is 16.00, which indicates a correct valuation of GILD.
- 95.56% of the companies in the same industry are more expensive than GILD, based on the Price/Forward Earnings ratio.
- When comparing the Price/Forward Earnings ratio of GILD to the average of the S&P500 Index (23.80), we can say GILD is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.35 | ||
| Fwd PE | 16 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, GILD is valued cheaper than 94.98% of the companies in the same industry.
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of GILD indicates a rather cheap valuation: GILD is cheaper than 96.14% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 18.57 | ||
| EV/EBITDA | 13.05 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates GILD does not grow enough to justify the current Price/Earnings ratio.
- GILD has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)2.05
PEG (5Y)6.14
EPS Next 2Y9.79%
EPS Next 3Y9.45%
5. GILD Dividend Analysis
5.1 Amount
- GILD has a Yearly Dividend Yield of 2.26%. Purely for dividend investing, there may be better candidates out there.
- Compared to an average industry Dividend Yield of 1.27, GILD pays a better dividend. On top of this GILD pays more dividend than 98.46% of the companies listed in the same industry.
- GILD's Dividend Yield is comparable with the S&P500 average which is at 1.91.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.26% |
5.2 History
- The dividend of GILD has a limited annual growth rate of 3.30%.
- GILD has paid a dividend for at least 10 years, which is a reliable track record.
- GILD has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)3.3%
Div Incr Years9
Div Non Decr Years9
5.3 Sustainability
- GILD pays out 47.04% of its income as dividend. This is a bit on the high side, but may be sustainable.
- GILD's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP47.04%
EPS Next 2Y9.79%
EPS Next 3Y9.45%
GILD Fundamentals: All Metrics, Ratios and Statistics
NASDAQ:GILD (3/19/2026, 10:42:01 AM)
141.41
+0.12 (+0.08%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-10 2026-02-10/amc
Earnings (Next)04-22 2026-04-22
Inst Owners92.51%
Inst Owner Change0.57%
Ins Owners0.08%
Ins Owner Change1.59%
Market Cap175.55B
Revenue(TTM)29.44B
Net Income(TTM)8.51B
Analysts81.05
Price Target159.01 (12.45%)
Short Float %1.49%
Short Ratio2.5
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.26% |
Yearly Dividend3.22
Dividend Growth(5Y)3.3%
DP47.04%
Div Incr Years9
Div Non Decr Years9
Ex-Date03-13 2026-03-13 (0.82)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.2%
Min EPS beat(2)0.73%
Max EPS beat(2)13.68%
EPS beat(4)3
Avg EPS beat(4)3.61%
Min EPS beat(4)-0.59%
Max EPS beat(4)13.68%
EPS beat(8)7
Avg EPS beat(8)10.97%
EPS beat(12)8
Avg EPS beat(12)7.27%
EPS beat(16)12
Avg EPS beat(16)9.04%
Revenue beat(2)2
Avg Revenue beat(2)1.64%
Min Revenue beat(2)0.98%
Max Revenue beat(2)2.29%
Revenue beat(4)2
Avg Revenue beat(4)-0.25%
Min Revenue beat(4)-3.96%
Max Revenue beat(4)2.29%
Revenue beat(8)6
Avg Revenue beat(8)1.67%
Revenue beat(12)8
Avg Revenue beat(12)0.99%
Revenue beat(16)12
Avg Revenue beat(16)2.6%
PT rev (1m)11.73%
PT rev (3m)18.87%
EPS NQ rev (1m)-8.06%
EPS NQ rev (3m)-7.26%
EPS NY rev (1m)-0.9%
EPS NY rev (3m)-0.29%
Revenue NQ rev (1m)-1.12%
Revenue NQ rev (3m)-1.76%
Revenue NY rev (1m)0.01%
Revenue NY rev (3m)0.46%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.35 | ||
| Fwd PE | 16 | ||
| P/S | 5.96 | ||
| P/FCF | 18.57 | ||
| P/OCF | 17.52 | ||
| P/B | 7.73 | ||
| P/tB | N/A | ||
| EV/EBITDA | 13.05 |
EPS(TTM)8.15
EY5.76%
EPS(NY)8.84
Fwd EY6.25%
FCF(TTM)7.62
FCFY5.39%
OCF(TTM)8.07
OCFY5.71%
SpS23.72
BVpS18.29
TBVpS-2.09
PEG (NY)2.05
PEG (5Y)6.14
Graham Number57.91
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 14.42% | ||
| ROE | 37.49% | ||
| ROCE | 24.94% | ||
| ROIC | 19.49% | ||
| ROICexc | 25.18% | ||
| ROICexgc | 81.81% | ||
| OM | 39.98% | ||
| PM (TTM) | 28.9% | ||
| GM | 78.83% | ||
| FCFM | 32.11% |
ROA(3y)8.12%
ROA(5y)8.16%
ROE(3y)21.59%
ROE(5y)23.19%
ROIC(3y)17.55%
ROIC(5y)16.76%
ROICexc(3y)21.91%
ROICexc(5y)20.22%
ROICexgc(3y)88.7%
ROICexgc(5y)94.18%
ROCE(3y)22.46%
ROCE(5y)21.44%
ROICexgc growth 3Y-8.45%
ROICexgc growth 5Y-2.47%
ROICexc growth 3Y8.85%
ROICexc growth 5Y10%
OM growth 3Y-1.4%
OM growth 5Y-0.11%
PM growth 3Y19.75%
PM growth 5Y125.27%
GM growth 3Y-0.18%
GM growth 5Y-0.66%
F-Score8
Asset Turnover0.5
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.97 | ||
| Debt/FCF | 2.64 | ||
| Debt/EBITDA | 1.52 | ||
| Cap/Depr | 20.4% | ||
| Cap/Sales | 1.91% | ||
| Interest Coverage | 11.36 | ||
| Cash Conversion | 68.94% | ||
| Profit Quality | 111.11% | ||
| Current Ratio | 1.55 | ||
| Quick Ratio | 1.4 | ||
| Altman-Z | 4.51 |
F-Score8
WACC8.21%
ROIC/WACC2.37
Cap/Depr(3y)20.34%
Cap/Depr(5y)24.78%
Cap/Sales(3y)1.96%
Cap/Sales(5y)2.14%
Profit Quality(3y)796.33%
Profit Quality(5y)548.85%
High Growth Momentum
Growth
EPS 1Y (TTM)76.79%
EPS 3Y3.88%
EPS 5Y2.83%
EPS Q2Q%-2.11%
EPS Next Y8.46%
EPS Next 2Y9.79%
EPS Next 3Y9.45%
EPS Next 5Y10.1%
Revenue 1Y (TTM)2.4%
Revenue growth 3Y2.57%
Revenue growth 5Y3.58%
Sales Q2Q%4.7%
Revenue Next Year3.46%
Revenue Next 2Y4.77%
Revenue Next 3Y4.94%
Revenue Next 5Y5.49%
EBIT growth 1Y8.73%
EBIT growth 3Y1.14%
EBIT growth 5Y3.47%
EBIT Next Year18.57%
EBIT Next 3Y11.36%
EBIT Next 5Y10.85%
FCF growth 1Y-8.25%
FCF growth 3Y4.25%
FCF growth 5Y4.69%
OCF growth 1Y-7.48%
OCF growth 3Y3.36%
OCF growth 5Y4.17%
GILEAD SCIENCES INC / GILD Fundamental Analysis FAQ
What is the ChartMill fundamental rating of GILEAD SCIENCES INC (GILD) stock?
ChartMill assigns a fundamental rating of 7 / 10 to GILD.
What is the valuation status for GILD stock?
ChartMill assigns a valuation rating of 6 / 10 to GILEAD SCIENCES INC (GILD). This can be considered as Fairly Valued.
How profitable is GILEAD SCIENCES INC (GILD) stock?
GILEAD SCIENCES INC (GILD) has a profitability rating of 9 / 10.
What is the valuation of GILEAD SCIENCES INC based on its PE and PB ratios?
The Price/Earnings (PE) ratio for GILEAD SCIENCES INC (GILD) is 17.35 and the Price/Book (PB) ratio is 7.73.
How sustainable is the dividend of GILEAD SCIENCES INC (GILD) stock?
The dividend rating of GILEAD SCIENCES INC (GILD) is 6 / 10 and the dividend payout ratio is 47.04%.